Ipratropium bromide and White blood cell count decreased - a phase IV clinical study of FDA data

Summary:

White blood cell count decreased is found among people who take Ipratropium bromide, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ipratropium bromide and have White blood cell count decreased. It is created by eHealthMe based on reports of 15,056 people who have side effects when taking Ipratropium bromide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 27, 2023

15,056 people reported to have side effects when taking Ipratropium bromide.
Among them, 112 people (0.74%) have White blood cell count decreased.


What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 15,253 Ipratropium bromide users for its effectiveness, alternative drugs and more.

What is White blood cell count decreased?

White blood cell count decreased is found to be associated with 2,970 drugs and 2,769 conditions by eHealthMe.

Number of Ipratropium bromide and White blood cell count decreased reports submitted per year:

Could Ipratropium bromide cause White blood cell count decreased?

Time on Ipratropium bromide when people have White blood cell count decreased *:

Click here to view

Gender of people who have White blood cell count decreased when taking Ipratropium bromide*:

Click here to view

Age of people who have White blood cell count decreased when taking Ipratropium bromide *:

Click here to view

Common drugs people take besides Ipratropium bromide *:

Click here to view

Common side effects people have besides White blood cell count decreased *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and have White blood cell count decreased?

Check whether White blood cell count decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was White blood cell count decreased and when was it recovered:

Expand to all the drugs that have ingredients of ipratropium bromide:

Alternative drugs to, pros and cons of Ipratropium bromide:

Common Ipratropium bromide side effects:

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

White blood cell count decreased treatments and more:

COVID vaccines that are related to White blood cell count decreased:

Common drugs associated with White blood cell count decreased:

All the drugs that are associated with White blood cell count decreased:

Common conditions associated with White blood cell count decreased:

All the conditions that are associated with White blood cell count decreased:

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Ipratropium bromide) and Ipratropium bromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: